ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Figure 1Loading Img

Characterization of Organic Anion Transporting Polypeptide (OATP) Expression and Its Functional Contribution to the Uptake of Substrates in Human Hepatocytes

View Author Information
Pfizer Global Research and Development, Department of Pharmacokinetics, Dynamics, and Metabolism, Groton, Connecticut 06340, United States
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan
§ Sugiyama Laboratory, RIKEN Innovation Center, RIKEN Research Cluster for Innovation, Yokohama, Japan
*Pharmacokinetics, Dynamics, and Metabolism, Pfizer, Inc., Groton, CT 06340. Tel: 860-715-6448. Fax: 860-686-5364. E-mail: [email protected]
Cite this: Mol. Pharmaceutics 2012, 9, 12, 3535–3542
Publication Date (Web):October 19, 2012
Copyright © 2012 American Chemical Society

    Article Views





    Other access options


    Abstract Image

    Since the substrate specificities of OATP1B1, 1B3, and 2B1 are broad and overlapping, the contribution of each isoform to the overall hepatic uptake is of concern when assessing transporter-mediated drug–drug interactions (DDIs) or genetic polymorphism impact in the clinic. Herein, we quantitatively measured OATP proteins in cryopreserved hepatocytes, sandwich-cultured human hepatocytes (SCHH), and the liver, and examined the relationship with functional uptake of OATP substrates in an effort to identify the OATP isoform(s) contributing to the hepatic uptake of pitavastatin. The modulation of OATP expression in SCHH was found to be lot-dependent. However, OATP protein measurements averaged from 5 lots of SCHH were comparable to that of suspended hepatocytes. All three OATP transporters in suspended hepatocytes and SCHH were significantly lower than those in the liver. In SCHH, the uptake of CCK-8 and pravastatin was found to be associated with the expression of OATP1B3 and OATP1B1, respectively. In suspended hepatocytes, OATP1B1 appeared to show a positive trend with respect to the uptake of pitavastatin, which suggests a selective contribution of OATP1B1 to pitavastatin transport and thus an OATP quantitative protein expression–activity relationship. While the passive diffusion of rosuvastatin in SCHH was consistent across hepatocyte lots, the passive diffusion of pitavastatin varied over a broad range (>4-fold) in suspended hepatocytes and was inversely correlated with transporter-mediated uptake, presumably due to cell membrane alterations imparted by cryopreservation. Collectively, SCHH maintains OATP protein expression and membrane integrity and, if feasible when considering research goals, would be considered a superior tool for the characterization of in vitro transport parameters without the complication of membrane leakage.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Cited By

    This article is cited by 92 publications.

    1. Zhongmin Wang, Ying Li, Taotao Peng, Ying Su, Xiaoting Luo, Wanjun Han, Hongjian Zhang, Jianqing Ruan, Chunshan Gui. Human Organic Anion Transporting Polypeptides 1B1, 1B3, and 2B1 Are Involved in the Hepatic Uptake of Phenolsulfonphthalein. ACS Omega 2021, 6 (51) , 35844-35851.
    2. Anna Vildhede, Emi Kimoto, A. David Rodrigues, Manthena V. S. Varma. Quantification of Hepatic Organic Anion Transport Proteins OAT2 and OAT7 in Human Liver Tissue and Primary Hepatocytes. Molecular Pharmaceutics 2018, 15 (8) , 3227-3235.
    3. Eleni Kotsampasakou, Stefan Brenner, Walter Jäger, and Gerhard F. Ecker . Identification of Novel Inhibitors of Organic Anion Transporting Polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) Using a Consensus Vote of Six Classification Models. Molecular Pharmaceutics 2015, 12 (12) , 4395-4404.
    4. Emi Kimoto, Rui Li, Renato J. Scialis, Yurong Lai, and Manthena V. S. Varma . Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-Glucuronide. Molecular Pharmaceutics 2015, 12 (11) , 3943-3952.
    5. Anna Vildhede, Jacek R. Wiśniewski, Agneta Norén, Maria Karlgren, and Per Artursson . Comparative Proteomic Analysis of Human Liver Tissue and Isolated Hepatocytes with a Focus on Proteins Determining Drug Exposure. Journal of Proteome Research 2015, 14 (8) , 3305-3314.
    6. Rajath Ramegowda, Pankaj Gupta. Abbreviated magnetic resonance imaging in hepatocellular carcinoma surveillance: A review. Indian Journal of Gastroenterology 2024, 101
    7. Jihoon Kwon, Michelle S. Kim, Christina Blagojevic, Jaymie Mailloux, Samantha Medwid, Rommel G. Tirona, Rennian Wang, Ute I. Schwarz. Differential effects of OATP2B1 on statin accumulation and toxicity in a beta cell model. Toxicology Mechanisms and Methods 2024, 34 (2) , 130-147.
    8. Regina D. Schnegelberger, Brianna Steiert, Philip J. Sandoval, Bruno Hagenbuch. Using a competitive counterflow assay to identify novel cationic substrates of OATP1B1 and OATP1B3. Frontiers in Physiology 2022, 13
    9. Seiji Miyauchi, Soo-Jin Kim, Wooin Lee, Yuichi Sugiyama. Consideration of albumin-mediated hepatic uptake for highly protein-bound anionic drugs: Bridging the gap of hepatic uptake clearance between in vitro and in vivo. Pharmacology & Therapeutics 2022, 229 , 107938.
    10. Adrian Köller, Jan Grzegorzewski, Matthias König. Physiologically Based Modeling of the Effect of Physiological and Anthropometric Variability on Indocyanine Green Based Liver Function Tests. Frontiers in Physiology 2021, 12
    11. Ryota Kikuchi, William J. Chiou, Kenneth R. Durbin, John P. Savaryn, Junli Ma, Arian Emami Riedmaier, Sonia M. de Morais, Gary J. Jenkins, Daniel A.J. Bow. Quantitation of Plasma Membrane Drug Transporters in Kidney Tissue and Cell Lines Using a Novel Proteomic Approach Enabled a Prospective Prediction of Metformin Disposition. Drug Metabolism and Disposition 2021, 49 (10) , 938-946.
    12. Chen Ning, Shengdi Su, Jiaming Li, Dexuan Kong, Hui Cai, Zhiying Qin, Han Xing, Xijing Chen, Jiake He. Evaluation of a Clinically Relevant Drug–Drug Interaction Between Rosuvastatin and Clopidogrel and the Risk of Hepatotoxicity. Frontiers in Pharmacology 2021, 12
    13. Roberto A. Abbiati, M. Guillaume Wientjes, Jessie L.-S. Au. Is It Time to Use Modeling of Cellular Transporter Homeostasis to Inform Drug-Drug Interaction Studies: Theoretical Considerations. The AAPS Journal 2021, 23 (5)
    14. Maria Karlgren, Pär Matsson. OATPs: The SLCO Family of Organic Anion Transporting Polypeptide Transporters. 2021, 143-159.
    15. Xiaomin Liang, Yurong Lai. Overcoming the shortcomings of the extended-clearance concept: a framework for developing a physiologically-based pharmacokinetic (PBPK) model to select drug candidates involving transporter-mediated clearance. Expert Opinion on Drug Metabolism & Toxicology 2021, 17 (8) , 869-886.
    16. Jaydeep Yadav, Mehdi El Hassani, Jasleen Sodhi, Volker M. Lauschke, Jessica H. Hartman, Laura E. Russell. Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data. Drug Metabolism Reviews 2021, 53 (2) , 207-233.
    17. Rongrong Jiang, Andrew Hart, Laurette Burgess, Dae-Shik Kim, Weidong George Lai, Vaishali Dixit. Prediction of Transporter-Mediated Drug-Drug Interactions and Phenotyping of Hepatobiliary Transporters Involved in the Clearance of E7766, a Novel Macrocycle-Bridged Dinucleotide. Drug Metabolism and Disposition 2021, 49 (3) , 265-275.
    18. Congrong Niu, Bill Smith, Yurong Lai. Transporter Gene Regulation in Sandwich Cultured Human Hepatocytes Through the Activation of Constitutive Androstane Receptor (CAR) or Aryl Hydrocarbon Receptor (AhR). Frontiers in Pharmacology 2021, 11
    19. Takashi Yoshikado, Wooin Lee, Kota Toshimoto, Kiyoe Morita, Aya Kiriake, Xiaoyan Chu, Nora Lee, Emi Kimoto, Manthena V.S. Varma, Ryota Kikuchi, Renato J. Scialis, Hong Shen, Naoki Ishiguro, Ralf Lotz, Albert P. Li, Kazuya Maeda, Hiroyuki Kusuhara, Yuichi Sugiyama. Evaluation of Hepatic Uptake of OATP1B Substrates by Short Term-Cultured Plated Human Hepatocytes: Comparison With Isolated Suspended Hepatocytes. Journal of Pharmaceutical Sciences 2021, 110 (1) , 376-387.
    20. Yi-an Bi, Sangwoo Ryu, David A. Tess, A. David Rodrigues, Manthena V. S. Varma. Effect of Human Plasma on Hepatic Uptake of Organic Anion–Transporting Polypeptide 1B Substrates: Studies Using Transfected Cells and Primary Human Hepatocytes. Drug Metabolism and Disposition 2021, 49 (1) , 72-83.
    21. Wooin Lee, Satoshi Koyama, Kiyoe Morita, Aya Kiriake, Ryota Kikuchi, Xiaoyan Chu, Nora Lee, Renato J. Scialis, Hong Shen, Emi Kimoto, Larry Tremaine, Naoki Ishiguro, Ralf Lotz, Kazuya Maeda, Hiroyuki Kusuhara, Yuichi Sugiyama. Cell-to-Medium Concentration Ratio Overshoot in the Uptake of Statins by Human Hepatocytes in Suspension, but Not in Monolayer: Kinetic Analysis Suggesting a Partial Loss of Functional OATP1Bs. The AAPS Journal 2020, 22 (6)
    22. Virág Székely, Izabel Patik, Orsolya Ungvári, Ágnes Telbisz, Gergely Szakács, Éva Bakos, Csilla Özvegy-Laczka. Fluorescent probes for the dual investigation of MRP2 and OATP1B1 function and drug interactions. European Journal of Pharmaceutical Sciences 2020, 151 , 105395.
    23. Ravindra V. Alluri, Rui Li, Manthena V. S. Varma. Transporter–enzyme interplay and the hepatic drug clearance: what have we learned so far?. Expert Opinion on Drug Metabolism & Toxicology 2020, 16 (5) , 387-401.
    24. Anna Vildhede, Emi Kimoto, Ryan M. Pelis, A. David Rodrigues, Manthena V.S. Varma. Quantitative Proteomics and Mechanistic Modeling of Transporter‐Mediated Disposition in Nonalcoholic Fatty Liver Disease. Clinical Pharmacology & Therapeutics 2020, 107 (5) , 1128-1137.
    25. Tatsuya Taniguchi, Alana Zanetti‐Yabur, Pijun Wang, Mykhaylo Usyk, Robert D. Burk, Allan W. Wolkoff. Interindividual Diversity in Expression of Organic Anion Uptake Transporters in Normal and Cirrhotic Human Liver. Hepatology Communications 2020, 4 (5) , 739-752.
    26. Rui-Feng Liang, Wen-Jing Ge, Xian-Mei Song, Jun-Ping Zhang, Wei-Feng Cui, She-Feng Zhang, Geng-Sheng Li. Involvement of organic anion-transporting polypeptides and organic cation transporter in the hepatic uptake of jatrorrhizine. Xenobiotica 2020, 50 (4) , 479-487.
    27. Juciene Aparecida Caris, Jhohann Richard de Lima Benzi, Flávio Falcão Lima de Souza, Renê Donizeti Ribeiro de Oliveira, Eduardo Antônio Donadi, Vera Lucia Lanchote. Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe. European Journal of Pharmaceutical Sciences 2020, 146 , 105264.
    28. Yingmin Nie, Jingjie Yang, Shuai Liu, Ruiqi Sun, Huihui Chen, Nan Long, Rui Jiang, Chunshan Gui. Genetic polymorphisms of human hepatic OATPs: functional consequences and effect on drug pharmacokinetics. Xenobiotica 2020, 50 (3) , 297-317.
    29. Xiaomin Liang, Kelly MacLennan Staiger, Ellen Riddle, Jia Hao, Yurong Lai. Role of transporters in drug disposition and drug-drug interactions. 2020, 311-337.
    30. Raju Khatri, John K. Fallon, Rebecca J.B. Rementer, Natasha T. Kulick, Craig R. Lee, Philip C. Smith. Targeted quantitative proteomic analysis of drug metabolizing enzymes and transporters by nano LC-MS/MS in the sandwich cultured human hepatocyte model. Journal of Pharmacological and Toxicological Methods 2019, 98 , 106590.
    31. Yi-an Bi, Chester Costales, Sumathy Mathialagan, Mark West, Soraya Eatemadpour, Sarah Lazzaro, Laurie Tylaska, Renato Scialis, Hui Zhang, John Umland, Emi Kimoto, David A. Tess, Bo Feng, Larry M. Tremaine, Manthena V. S. Varma, A. David Rodrigues. Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: “SLC-Phenotyping” Using Primary Human Hepatocytes. Journal of Pharmacology and Experimental Therapeutics 2019, 370 (1) , 72-83.
    32. Vineet Kumar, Laurent Salphati, Cornelis E. C. A. Hop, Guangqing Xiao, Yurong Lai, Anita Mathias, Xiaoyan Chu, W. Griffith Humphreys, Mingxiang Liao, Scott Heyward, Jashvant D. Unadkat. A Comparison of Total and Plasma Membrane Abundance of Transporters in Suspended, Plated, Sandwich-Cultured Human Hepatocytes Versus Human Liver Tissue Using Quantitative Targeted Proteomics and Cell Surface Biotinylation. Drug Metabolism and Disposition 2019, 47 (4) , 350-357.
    33. Olivier Fardel, Amélie Moreau, Marc Le Vée, Claire Denizot, Yannick Parmentier. Evaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes. European Journal of Drug Metabolism and Pharmacokinetics 2019, 44 (1) , 13-30.
    34. Soo-Jin Kim, Kyeong-Ryoon Lee, Seiji Miyauchi, Yuichi Sugiyama. Extrapolation of In Vivo Hepatic Clearance from In Vitro Uptake Clearance by Suspended Human Hepatocytes for Anionic Drugs with High Binding to Human Albumin: Improvement of In Vitro-to-In Vivo Extrapolation by Considering the “Albumin-Mediated” Hepatic Uptake Mechanism on the Basis of the “Facilitated-Dissociation Model”. Drug Metabolism and Disposition 2019, 47 (2) , 94-103.
    35. Xiaodong Liu. SLC Family Transporters. 2019, 101-202.
    36. Emi Kimoto, Sumathy Mathialagan, Laurie Tylaska, Mark Niosi, Jian Lin, Anthony A. Carlo, David A. Tess, Manthena V. S. Varma. Organic Anion Transporter 2–Mediated Hepatic Uptake Contributes to the Clearance of High-Permeability–Low-Molecular-Weight Acid and Zwitterion Drugs: Evaluation Using 25 Drugs. Journal of Pharmacology and Experimental Therapeutics 2018, 367 (2) , 322-334.
    37. Sumathy Mathialagan, Chester Costales, Laurie Tylaska, Emi Kimoto, Anna Vildhede, Jillian Johnson, Nathaniel Johnson, Takami Sarashina, Kenta Hashizume, Caleb D. Isringhausen, Lydia M. M. Vermeer, Andrea R. Wolff, A. David Rodrigues. In vitro studies with two human organic anion transporters: OAT2 and OAT7. Xenobiotica 2018, 48 (10) , 1037-1049.
    38. Pallabi Mitra, Samantha Weinheimer, Meeghan Michalewicz, Mitchell E. Taub. Prediction and Quantification of Hepatic Transporter-Mediated Uptake of Pitavastatin Utilizing a Combination of the Relative Activity Factor Approach and Mechanistic Modeling. Drug Metabolism and Disposition 2018, 46 (7) , 953-963.
    39. Anna Vildhede, Chuong Nguyen, Brian K. Erickson, Ryan C. Kunz, Richard Jones, Emi Kimoto, Francis Bourbonais, A. David Rodrigues, Manthena V.S. Varma. Comparison of Proteomic Quantification Approaches for Hepatic Drug Transporters: Multiplexed Global Quantitation Correlates with Targeted Proteomic Quantitation. Drug Metabolism and Disposition 2018, 46 (5) , 692-696.
    40. Jialin Mao, Utkarsh Doshi, Matthew Wright, Cornelis E. C. A. Hop, Albert P. Li, Yuan Chen. Prediction of the Pharmacokinetics of Pravastatin as an OATP Substrate Using Plateable Human Hepatocytes With Human Plasma Data and PBPK Modeling. CPT: Pharmacometrics & Systems Pharmacology 2018, 7 (4) , 251-258.
    41. Xiaomei Gu, Qing Xiao, Qian Ruan, Yuezhong Shu, Ashok Dongre, Ramaswamy Iyer, W. Griffith Humphreys, Yurong Lai. Comparative untargeted proteomic analysis of ADME proteins and tumor antigens for tumor cell lines. Acta Pharmaceutica Sinica B 2018, 8 (2) , 252-260.
    42. Seiji Miyauchi, Masayuki Masuda, Soo-Jin Kim, Yuudai Tanaka, Kyeong-Ryoon Lee, Shouko Iwakado, Momoko Nemoto, Shotaro Sasaki, Kazumi Shimono, Yoshio Tanaka, Yuichi Sugiyama. The Phenomenon of Albumin-Mediated Hepatic Uptake of Organic Anion Transport Polypeptide Substrates: Prediction of the In Vivo Uptake Clearance from the In Vitro Uptake by Isolated Hepatocytes Using a Facilitated-Dissociation Model. Drug Metabolism and Disposition 2018, 46 (3) , 259-267.
    43. Michelle Schaefer, Gaku Morinaga, Akiko Matsui, Gerhard Schänzle, Daniel Bischoff, Roderich D. Süssmuth. Quantitative Expression of Hepatobiliary Transporters and Functional Uptake of Substrates in Hepatic Two-Dimensional Sandwich Cultures: A Comparative Evaluation of Upcyte and Primary Human Hepatocytes. Drug Metabolism and Disposition 2018, 46 (2) , 166-177.
    44. Hoa Q. Nguyen, Jian Lin, Emi Kimoto, Ernesto Callegari, Susanna Tse, R. Scott Obach. Prediction of Losartan-Active Carboxylic Acid Metabolite Exposure Following Losartan Administration Using Static and Physiologically Based Pharmacokinetic Models. Journal of Pharmaceutical Sciences 2017, 106 (9) , 2758-2770.
    45. Emi Kimoto, Yi-An Bi, Rachel E. Kosa, Larry M. Tremaine, Manthena V.S. Varma. Hepatobiliary Clearance Prediction: Species Scaling From Monkey, Dog, and Rat, and In Vitro–In Vivo Extrapolation of Sandwich-Cultured Human Hepatocytes Using 17 Drugs. Journal of Pharmaceutical Sciences 2017, 106 (9) , 2795-2804.
    46. Carina Cantrill, J. Brian Houston. Understanding the Interplay Between Uptake and Efflux Transporters Within In Vitro Systems in Defining Hepatocellular Drug Concentrations. Journal of Pharmaceutical Sciences 2017, 106 (9) , 2815-2825.
    47. Keith Riccardi, Jian Lin, Zhenhong Li, Mark Niosi, Sangwoo Ryu, Wenyi Hua, Karen Atkinson, Rachel E. Kosa, John Litchfield, Li Di. Novel Method to Predict In Vivo Liver-to-Plasma K puu for OATP Substrates Using Suspension Hepatocytes. Drug Metabolism and Disposition 2017, 45 (5) , 576-580.
    48. Q Wang, M Zheng, T Leil. Investigating Transporter-Mediated Drug-Drug Interactions Using a Physiologically Based Pharmacokinetic Model of Rosuvastatin. CPT: Pharmacometrics & Systems Pharmacology 2017, 6 (4) , 228-238.
    49. T Yoshikado, K Yoshida, N Kotani, T Nakada, R Asaumi, K Toshimoto, K Maeda, H Kusuhara, Y Sugiyama. Quantitative Analyses of Hepatic OATP‐Mediated Interactions Between Statins and Inhibitors Using PBPK Modeling With a Parameter Optimization Method. Clinical Pharmacology & Therapeutics 2016, 100 (5) , 513-523.
    50. Kavisha Singh, Bruce Peyser, Gloria Trujillo, Nicholas Milazzo, Dillon Savard, Susanne B Haga, Michael Musty, Deepak Voora. Rationale and design of the SLCO1B1 genotype guided statin therapy trial. Pharmacogenomics 2016, 17 (17) , 1873-1880.
    51. H. J. Burt, A. E. Riedmaier, M. D. Harwood, H. K. Crewe, K. L. Gill, S. Neuhoff. Abundance of Hepatic Transporters in Caucasians: A Meta-Analysis. Drug Metabolism and Disposition 2016, 44 (10) , 1550-1561.
    52. Manthena V. Varma, Ayman F. El‐Kattan. Transporter‐Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models. The Journal of Clinical Pharmacology 2016, 56 (S7)
    53. Houfu Liu, Jasminder Sahi. Role of Hepatic Drug Transporters in Drug Development. The Journal of Clinical Pharmacology 2016, 56 (S7)
    54. Michael Sørensen, Ole Lajord Munk, Nikolaj W. Ørntoft, Kim Frisch, Kasper Jarlhelt Andersen, Frank Viborg Mortensen, Aage Kristian Olsen Alstrup, Peter Ott, Alan F. Hofmann, Susanne Keiding. Hepatobiliary Secretion Kinetics of Conjugated Bile Acids Measured in Pigs by 11 C-Cholylsarcosine PET. Journal of Nuclear Medicine 2016, 57 (6) , 961-966.
    55. William Brian, Larry M Tremaine, Million Arefayene, Ruben de Kanter, Raymond Evers, Yingying Guo, James Kalabus, Wen Lin, Cho-Ming Loi, Guangqing Xiao. Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG. Pharmacogenomics 2016, 17 (6) , 615-631.
    56. A. Vildhede, A. Mateus, E. K. Khan, Y. Lai, M. Karlgren, P. Artursson, M. C. Kjellsson. Mechanistic Modeling of Pitavastatin Disposition in Sandwich-Cultured Human Hepatocytes: A Proteomics-Informed Bottom-Up Approach. Drug Metabolism and Disposition 2016, 44 (4) , 505-516.
    57. Kyunghee Yang, Cen Guo, Jeffrey L. Woodhead, Robert L. St. Claire, Paul B. Watkins, Scott Q. Siler, Brett A. Howell, Kim L.R. Brouwer. Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury. Journal of Pharmaceutical Sciences 2016, 105 (2) , 443-459.
    58. Donna A. Volpe. Transporter assays as useful in vitro tools in drug discovery and development. Expert Opinion on Drug Discovery 2016, 11 (1) , 91-103.
    59. Hajar Al Feteisi, Brahim Achour, Amin Rostami-Hodjegan, Jill Barber. Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro – in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques. Expert Opinion on Drug Metabolism & Toxicology 2015, 11 (9) , 1357-1369.
    60. Kuan-wei Peng, James Bacon, Ming Zheng, Yingying Guo, Michael Zhuo Wang. Ethnic Variability in the Expression of Hepatic Drug Transporters: Absolute Quantification by an Optimized Targeted Quantitative Proteomic Approach. Drug Metabolism and Disposition 2015, 43 (7) , 1045-1055.
    61. Albert P. Li. Evaluation of Adverse Drug Properties with Cryopreserved Human Hepatocytes and the Integrated Discrete Multiple Organ Co-culture (IdMOC TM ) System. Toxicological Research 2015, 31 (2) , 137-149.
    62. Justine Badée, Brahim Achour, Amin Rostami-Hodjegan, Aleksandra Galetin. Meta-Analysis of Expression of Hepatic Organic Anion–Transporting Polypeptide (OATP) Transporters in Cellular Systems Relative to Human Liver Tissue. Drug Metabolism and Disposition 2015, 43 (4) , 424-432.
    63. Manthena V. Varma, Yi-an Bi, Emi Kimoto, Jian Lin. Quantitative Prediction of Transporter- and Enzyme-Mediated Clinical Drug-Drug Interactions of Organic Anion-Transporting Polypeptide 1B1 Substrates Using a Mechanistic Net-Effect Model. Journal of Pharmacology and Experimental Therapeutics 2014, 351 (1) , 214-223.
    64. Michael Gertz, Nikolaos Tsamandouras, Carolina Säll, J. Brian Houston, Aleksandra Galetin. Reduced Physiologically-Based Pharmacokinetic Model of Repaglinide: Impact of OATP1B1 and CYP2C8 Genotype and Source of In Vitro Data on the Prediction of Drug-Drug Interaction Risk. Pharmaceutical Research 2014, 31 (9) , 2367-2382.
    65. Thomayant Prueksaritanont, Xiaoyan Chu, Raymond Evers, Stephanie O. Klopfer, Luzelena Caro, Prajakti A. Kothare, Cynthia Dempsey, Scott Rasmussen, Robert Houle, Grace Chan, Xiaoxin Cai, Robert Valesky, Iain P. Fraser, S. Aubrey Stoch. Pitavastatin is a more sensitive and selective organic anion‐transporting polypeptide 1B clinical probe than rosuvastatin. British Journal of Clinical Pharmacology 2014, 78 (3) , 587-598.
    66. Annett Kunze, Jörg Huwyler, Gian Camenisch, Birk Poller. Prediction of Organic Anion-Transporting Polypeptide 1B1- and 1B3-Mediated Hepatic Uptake of Statins Based on Transporter Protein Expression and Activity Data. Drug Metabolism and Disposition 2014, 42 (9) , 1514-1521.
    67. Rui Li, Hugh A. Barton, Manthena V. Varma. Prediction of Pharmacokinetics and Drug–Drug Interactions When Hepatic Transporters are Involved. Clinical Pharmacokinetics 2014, 53 (8) , 659-678.
    68. Bo Feng, Manthena V Varma, Chester Costales, Hui Zhang, Larry Tremaine. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery. Expert Opinion on Drug Discovery 2014, 9 (8) , 873-890.
    69. Anna Vildhede, Maria Karlgren, Elin K. Svedberg, Jacek R. Wisniewski, Yurong Lai, Agneta Norén, Per Artursson. Hepatic Uptake of Atorvastatin: Influence of Variability in Transporter Expression on Uptake Clearance and Drug-Drug Interactions . Drug Metabolism and Disposition 2014, 42 (7) , 1210-1218.
    70. Xi Qiu, Hui Zhang, Yurong Lai. Quantitative Targeted Proteomics for Membrane Transporter Proteins: Method and Application. The AAPS Journal 2014, 16 (4) , 714-726.
    71. Manthena V. S. Varma, Renato J. Scialis, Jian Lin, Yi-An Bi, Charles J. Rotter, Theunis C. Goosen, Xin Yang. Mechanism-Based Pharmacokinetic Modeling to Evaluate Transporter-Enzyme Interplay in Drug Interactions and Pharmacogenetics of Glyburide. The AAPS Journal 2014, 16 (4) , 736-748.
    72. Heidi J. Einolf, Imad Hanna. Management and Mitigation of Human Drug–drug Interaction Risks in the Drug Discovery and Development Phases. 2014, 353-396.
    73. Patrik Lundquist, Johan Lööf, Urban Fagerholm, Ingemo Sjögren, Jenny Johansson, Sveinn Briem, Janet Hoogstraate, Lovisa Afzelius, Tommy B. Andersson. Prediction of In Vivo Rat Biliary Drug Clearance from an In Vitro Hepatocyte Efflux Model. Drug Metabolism and Disposition 2014, 42 (3) , 459-468.
    74. Patrik Lundquist, Gunilla Englund, Cristine Skogastierna, Johan Lööf, Jenny Johansson, Janet Hoogstraate, Lovisa Afzelius, Tommy B. Andersson. Functional ATP-Binding Cassette Drug Efflux Transporters in Isolated Human and Rat Hepatocytes Significantly Affect Assessment of Drug Disposition. Drug Metabolism and Disposition 2014, 42 (3) , 448-458.
    75. Patrik Lundquist, Johan Lööf, Anna-Karin Sohlenius-Sternbeck, Eva Floby, Jenny Johansson, Johan Bylund, Janet Hoogstraate, Lovisa Afzelius, Tommy B. Andersson. The Impact of Solute Carrier (SLC) Drug Uptake Transporter Loss in Human and Rat Cryopreserved Hepatocytes on Clearance Predictions. Drug Metabolism and Disposition 2014, 42 (3) , 469-480.
    76. Gunilla Englund, Patrik Lundquist, Cristine Skogastierna, Jenny Johansson, Janet Hoogstraate, Lovisa Afzelius, Tommy B. Andersson, Denis Projean. Cytochrome P450 Inhibitory Properties of Common Efflux Transporter Inhibitors. Drug Metabolism and Disposition 2014, 42 (3) , 441-447.
    77. Scott J. Brantley, Aneesh A. Argikar, Yvonne S. Lin, Swati Nagar, Mary F. Paine. Herb–Drug Interactions: Challenges and Opportunities for Improved Predictions. Drug Metabolism and Disposition 2014, 42 (3) , 301-317.
    78. Bhagwat Prasad, Jashvant D. Unadkat. Comparison of Heavy Labeled (SIL) Peptide versus SILAC Protein Internal Standards for LC-MS/MS Quantification of Hepatic Drug Transporters. International Journal of Proteomics 2014, 2014 , 1-11.
    79. Albert P Li. Biomarkers and human hepatocytes. Biomarkers in Medicine 2014, 8 (2) , 173-183.
    80. Nathan D. Pfeifer, Rhiannon N. Hardwick, Kim L.R. Brouwer. Role of Hepatic Efflux Transporters in Regulating Systemic and Hepatocyte Exposure to Xenobiotics. Annual Review of Pharmacology and Toxicology 2014, 54 (1) , 509-535.
    81. Anne M. Larson, Matthew Hauswald. Normal Functional Biology of the Liver. 2014, 23-51.
    82. Anne M. Larson. Cholestasis in the Hospitalized Patient. 2014, 201-228.
    83. Aleksandra Galetin. Rationalizing Underprediction of Drug Clearance from Enzyme and Transporter Kinetic Data: From In Vitro Tools to Mechanistic Modeling. 2014, 255-288.
    84. Bhagwat Prasad, Raymond Evers, Anshul Gupta, Cornelis E. C. A. Hop, Laurent Salphati, Suneet Shukla, Suresh V. Ambudkar, Jashvant D. Unadkat. Interindividual Variability in Hepatic Organic Anion-Transporting Polypeptides and P-Glycoprotein (ABCB1) Protein Expression: Quantification by Liquid Chromatography Tandem Mass Spectroscopy and Influence of Genotype, Age, and Sex. Drug Metabolism and Disposition 2014, 42 (1) , 78-88.
    85. Li Di, Bo Feng, Theunis C. Goosen, Yurong Lai, Stefanus J. Steyn, Manthena V. Varma, R. Scott Obach. A Perspective on the Prediction of Drug Pharmacokinetics and Disposition in Drug Research and Development. Drug Metabolism and Disposition 2013, 41 (12) , 1975-1993.
    86. Yi‐an Bi, Xi Qiu, Charles J. Rotter, Emi Kimoto, Mary Piotrowski, Manthena V. Varma, Ayman F. EI‐Kattan, Yurong Lai. Quantitative assessment of the contribution of sodium‐dependent taurocholate co‐transporting polypeptide (NTCP) to the hepatic uptake of rosuvastatin, pitavastatin and fluvastatin. Biopharmaceutics & Drug Disposition 2013, 34 (8) , 452-461.
    87. Xi Qiu, Yi-An Bi, Larissa M. Balogh, Yurong Lai. Absolute measurement of species differences in sodium taurocholate cotransporting polypeptide (NTCP/Ntcp) and its modulation in cultured hepatocytes. Journal of Pharmaceutical Sciences 2013, 102 (9) , 3252-3263.
    88. Manthena V. S. Varma, Yurong Lai, Bo Feng, John Litchfield, Theunis C. Goosen, Arthur Bergman. Response to the Comment on the Article “Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions”. Pharmaceutical Research 2013, 30 (6) , 1469-1470.
    89. Manthena V. S. Varma, Jian Lin, Yi-An Bi, Charles J. Rotter, Odette A. Fahmi, Justine L. Lam, Ayman F. El-Kattan, Theunis C. Goosen, Yurong Lai. Quantitative Prediction of Repaglinide-Rifampicin Complex Drug Interactions Using Dynamic and Static Mechanistic Models: Delineating Differential CYP3A4 Induction and OATP1B1 Inhibition Potential of Rifampicin. Drug Metabolism and Disposition 2013, 41 (5) , 966-974.
    90. Manthena V. S. Varma, Yurong Lai, Emi Kimoto, Theunis C. Goosen, Ayman F. El-Kattan, Vikas Kumar. Mechanistic Modeling to Predict the Transporter- and Enzyme-Mediated Drug-Drug Interactions of Repaglinide. Pharmaceutical Research 2013, 30 (4) , 1188-1199.
    91. Pär Nordell, Petter Svanberg, James Bird, Ken Grime. Predicting Metabolic Clearance for Drugs That Are Actively Transported into Hepatocytes: Incubational Binding as a Consequence of in Vitro Hepatocyte Concentration Is a Key Factor. Drug Metabolism and Disposition 2013, 41 (4) , 836-843.
    92. Yurong Lai. Transporter study methodologies. 2013, 675-718.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect